UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 66

of 'Systemic treatment for unresectable malignant pleural mesothelioma'

66
TI
Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma.
AU
Porta C, Mutti L, Tassi G
SO
Cancer Chemother Pharmacol. 2007;59(1):149. Epub 2006 Apr 25.
 
AD
PMID